CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Hyper or Normobaric Oxygen

Hyper or Normobaric Oxygen: Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chronically low oxygen such as from severe COPD or cystic fibrosis. Oxygen can be given in a number of ways including nasal cannula, face mask, and inside a hyperbaric chamber.

Oxygen is required for normal cell metabolism. Excessively high concentrations can cause oxygen toxicity such as lung damage or result in respiratory failure in those who are predisposed. Higher oxygen concentrations also increase the risk of fires, particularly while smoking, and without humidification can also dry out the nose. The target oxygen saturation recommended depends on the condition being treated. In most conditions a saturation of 94-98% is recommended, while in those at risk of carbon dioxide retention saturations of 88-92% are preferred, and in those with carbon monoxide toxicity or cardiac arrest they should be as high as possible. Air is typically 21% oxygen by volume while oxygen therapy increases this by some amount up to 100%.

The use of oxygen in medicine became common around 1917. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The cost of home oxygen is about 150 USD a month in Brazil and 400 USD a month in the United States. Home oxygen can be provided either by oxygen tanks or an oxygen concentrator. Oxygen is believed to be the most common treatment given in hospitals in the developed world.

  • Hyper or Normobaric Oxygen

  • Hyper or Normobaric Oxygen

    facebook Share on Facebook

    Hyper or Normobaric Oxygen: Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chronically low oxygen such as from severe COPD or cystic fibrosis. Oxygen can be given in a number of ways including nasal cannula, face mask, and inside a hyperbaric chamber.

  • Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review

    facebook Share on Facebook
    Abstract Title:

    [Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review].

    Abstract Source:

    Schmerz. 2008 Apr;22(2):129-32, 134-6. PMID: 17885769

    Abstract Author(s):

    A Schnabel, M Bennet, F Schuster, N Roewer, P Kranke

    Article Affiliation:

    Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Münster, Germany.

    Abstract:

    BACKGROUND:The aim of this systematic review was to assess the benefits and harms of supplemental oxygen (HBOT/NBOT) for treating and preventing migraine and cluster headaches.

    MATERIAL AND METHODS:All randomized trials comparing the effect of supplemental oxygen on migraine or cluster headache with those that exclude supplemental oxygen were included in this review. The systematic search included all relevant sources according to the paradigms of the Cochrane Collaboration. Data were analyzed with RevMan 4.2.

    RESULTS:Nine trials involving 201 participants satisfied the inclusion criteria. HBOT was effective in relieving an acute migraine and seemed to be sufficient in the treatment of an acute cluster attack. NBOT was effective in terminating acute cluster headache compared to sham treatment, but not in comparison to sublingual ergotamine. There was no evidence for any prophylactic effects. Serious adverse effects were not noted in the trials investigated.

    CONCLUSIONS:There is some evidence that HBOT is effective for termination of acute migraine. NBOT was similarly effective in cluster headache, however with sparse data. Because of costs and poor availability HBOT cannot be regarded as a routine therapy. Further indications in the case of treatment failure using standard therapy need to be defined based on data of future clinical trials.

  • Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review

    facebook Share on Facebook
    Abstract Title:

    [Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review].

    Abstract Source:

    Schmerz. 2008 Apr;22(2):129-32, 134-6. PMID: 17885769

    Abstract Author(s):

    A Schnabel, M Bennet, F Schuster, N Roewer, P Kranke

    Article Affiliation:

    Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Münster, Germany.

    Abstract:

    BACKGROUND:The aim of this systematic review was to assess the benefits and harms of supplemental oxygen (HBOT/NBOT) for treating and preventing migraine and cluster headaches.

    MATERIAL AND METHODS:All randomized trials comparing the effect of supplemental oxygen on migraine or cluster headache with those that exclude supplemental oxygen were included in this review. The systematic search included all relevant sources according to the paradigms of the Cochrane Collaboration. Data were analyzed with RevMan 4.2.

    RESULTS:Nine trials involving 201 participants satisfied the inclusion criteria. HBOT was effective in relieving an acute migraine and seemed to be sufficient in the treatment of an acute cluster attack. NBOT was effective in terminating acute cluster headache compared to sham treatment, but not in comparison to sublingual ergotamine. There was no evidence for any prophylactic effects. Serious adverse effects were not noted in the trials investigated.

    CONCLUSIONS:There is some evidence that HBOT is effective for termination of acute migraine. NBOT was similarly effective in cluster headache, however with sparse data. Because of costs and poor availability HBOT cannot be regarded as a routine therapy. Further indications in the case of treatment failure using standard therapy need to be defined based on data of future clinical trials.

  • Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review

    facebook Share on Facebook
    Abstract Title:

    [Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review].

    Abstract Source:

    Schmerz. 2008 Apr;22(2):129-32, 134-6. PMID: 17885769

    Abstract Author(s):

    A Schnabel, M Bennet, F Schuster, N Roewer, P Kranke

    Article Affiliation:

    Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster, Münster, Germany.

    Abstract:

    BACKGROUND:The aim of this systematic review was to assess the benefits and harms of supplemental oxygen (HBOT/NBOT) for treating and preventing migraine and cluster headaches.

    MATERIAL AND METHODS:All randomized trials comparing the effect of supplemental oxygen on migraine or cluster headache with those that exclude supplemental oxygen were included in this review. The systematic search included all relevant sources according to the paradigms of the Cochrane Collaboration. Data were analyzed with RevMan 4.2.

    RESULTS:Nine trials involving 201 participants satisfied the inclusion criteria. HBOT was effective in relieving an acute migraine and seemed to be sufficient in the treatment of an acute cluster attack. NBOT was effective in terminating acute cluster headache compared to sham treatment, but not in comparison to sublingual ergotamine. There was no evidence for any prophylactic effects. Serious adverse effects were not noted in the trials investigated.

    CONCLUSIONS:There is some evidence that HBOT is effective for termination of acute migraine. NBOT was similarly effective in cluster headache, however with sparse data. Because of costs and poor availability HBOT cannot be regarded as a routine therapy. Further indications in the case of treatment failure using standard therapy need to be defined based on data of future clinical trials.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.